ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 56 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $367,000 | -52.8% | 340,000 | -54.6% | 0.05% | -51.6% |
| Q2 2014 | $778,000 | +0.9% | 748,200 | 0.0% | 0.10% | +1.1% |
| Q1 2014 | $771,000 | -11.2% | 748,200 | 0.0% | 0.09% | -16.1% |
| Q4 2013 | $868,000 | -30.9% | 748,200 | 0.0% | 0.11% | -32.9% |
| Q3 2013 | $1,257,000 | -16.0% | 748,200 | 0.0% | 0.17% | -16.5% |
| Q2 2013 | $1,496,000 | – | 748,200 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALGERT GLOBAL LLC | 124,891 | $85,000 | 0.04% |
| Icahn Capital | 5,904,863 | $4,030,000 | 0.01% |
| SEIZERT CAPITAL PARTNERS, LLC | 414,810 | $283,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 473,708 | $323,000 | 0.01% |
| Anson Funds Management LP | 25,000 | $17,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 106,908 | $72,000 | 0.01% |
| Spark Investment Management LLC | 57,500 | $39,000 | 0.01% |
| Renaissance Technologies | 3,501,585 | $2,390,000 | 0.01% |
| Concert Wealth Management Inc. | 45,938 | $30,000 | 0.00% |
| CSS LLC/IL | 96,572 | $66,000 | 0.00% |